Australia Targets Patients, Doctors In Biosimilar Awareness Campaign
This article was originally published in The Pink Sheet Daily
Executive Summary
The Australian government is seeking feedback on a biosimilar awareness initiative for health professionals and consumers that will benefit from A$20m ($14.5m) in funding over the 2015-2018 period.
You may also be interested in...
FDA Biosimilar Education Campaign Will Need To Be Targeted
Sen. Cassidy does not think additional appropriations are needed for a massive provider and patient education on biosimilars.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.